Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Chi

Showing results (271-280 of 410) with videos related to

Pageof 41
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2017
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder CancerGillian Vandekerkhove, Tilman Todenhöfer, Matti Annala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2011
Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine gliomaBarbara S Paugh, Alberto Broniscer, Chunxu Qu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022
Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfoundKim N Chi, Alan Barnicle, Caroline Sibilla, et al.
Investigational New Drugs|May 3, 2014
A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patientsAnna Spreafico, Kim N Chi, Srikala S Sridhar, et al.
Cancer|March 10, 2021
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancerDaniel H Kwon, Jonathan Chou, Steven M Yip, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 2020
HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studiesD J Khalaf, I M Aragón, M Annala, et al.
NPJ Precision Oncology|March 14, 2023
A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomesElie J Ritch, Cameron Herberts, Evan W Warner, et al.
Journal of Neuro-Oncology|October 16, 2015
Myxopapillary ependymomas in children: imaging, treatment and outcomesPratiti Bandopadhayay, V Michelle Silvera, Pedro D S C Ciarlini, et al.
Journal of Neuro-Oncology|July 23, 2017
Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survivalAmanda E Marinoff, Clement Ma, Dongjing Guo, et al.
The New England Journal of Medicine|September 21, 2020
Survival with Olaparib in Metastatic Castration-Resistant Prostate CancerMaha Hussain, Joaquin Mateo, Karim Fizazi, et al.
Pageof 41

Showing results (271-280 of 410) with videos related to

Sort By:
Pageof 41
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2017
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder CancerGillian Vandekerkhove, Tilman Todenhöfer, Matti Annala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2011
Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine gliomaBarbara S Paugh, Alberto Broniscer, Chunxu Qu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022
Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfoundKim N Chi, Alan Barnicle, Caroline Sibilla, et al.
Investigational New Drugs|May 3, 2014
A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patientsAnna Spreafico, Kim N Chi, Srikala S Sridhar, et al.
Cancer|March 10, 2021
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancerDaniel H Kwon, Jonathan Chou, Steven M Yip, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 24, 2020
HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studiesD J Khalaf, I M Aragón, M Annala, et al.
NPJ Precision Oncology|March 14, 2023
A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomesElie J Ritch, Cameron Herberts, Evan W Warner, et al.
Journal of Neuro-Oncology|October 16, 2015
Myxopapillary ependymomas in children: imaging, treatment and outcomesPratiti Bandopadhayay, V Michelle Silvera, Pedro D S C Ciarlini, et al.
Journal of Neuro-Oncology|July 23, 2017
Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survivalAmanda E Marinoff, Clement Ma, Dongjing Guo, et al.
The New England Journal of Medicine|September 21, 2020
Survival with Olaparib in Metastatic Castration-Resistant Prostate CancerMaha Hussain, Joaquin Mateo, Karim Fizazi, et al.
Pageof 41